VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Lexaria Bioscience Corp. (LEXX) Total Return Calculator with Dividends Reinvested

Lexaria Bioscience Corp.

Popular:

The total return for Lexaria Bioscience Corp. (LEXX) stock is -42.47% over the past 12 months. So far it's down 6.76% this year. The 5-year total return is -90.20%, meaning $10,000 invested in LEXX stock 5 years ago would be worth $980 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in LEXX 1 year ago, it would be worth $5,646 today — you'd have lost $4,354.

With Dividends Reinvested$5,646-43.54%

Price Only (No DRIP)$5,646-43.54%

Period2025-05-09 → 2026-05-08

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in LEXX

1Y$5,753-$4,247 (-42.5%)-42.5% CAGR

3Y$5,978-$4,022 (-40.2%)-15.8% CAGR

5Y$980-$9,020 (-90.2%)-37.2% CAGR

10Y$1,361-$8,639 (-86.4%)-18.1% CAGR

15Y$1,361-$8,639 (-86.4%)-12.4% CAGR

20Y$1,361-$8,639 (-86.4%)-9.5% CAGR

30Y$1,361-$8,639 (-86.4%)-6.4% CAGR

Lexaria Bioscience Corp. did not pay dividends during this period. Total return = price return.

Loading LEXX total return...

As of 2026-05-09

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-6.76%	—	-6.76%	—	$9,324
1Y	-42.47%	-42.47%	-42.47%	—	$5,753
3Y	-40.22%	-15.76%	-40.22%	—	$5,978
5Y	-90.20%	-37.15%	-90.20%	—	$980
10Y	-86.39%	-18.08%	-86.39%	—	$1,361
15Y	-86.39%	-12.45%	-86.39%	—	$1,361
20Y	-86.39%	-9.49%	-86.39%	—	$1,361
30Y	-86.39%	-6.43%	-86.39%	—	$1,361

Risk & Highlights

Best Year+62.79%2024

Worst Year-73.17%2025

Max Drawdown-65.29%2025-09-25 → 2025-12-26

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+6.88%	+6.88%	—	+0.41%	+6.5pp
2025	-73.17%	-73.17%	—	+16.64%	-89.8pp
2024	+62.79%	+62.79%	—	+24.00%	+38.8pp
2023	-50.98%	-50.98%	—	+24.81%	-75.8pp
2022	-42.52%	-42.52%	—	-19.95%	-22.6pp

LEXX underperformed the S&P 500 by 73.01pp over the past year (-42.47% vs +30.54%).

Loading summary...

LEXX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
LEXXLexaria Bioscience Corp.	$14M	-36.2%	-6.8%	-42.5%	—	-40.2%	-90.2%	-86.4%
ATAIAtai Beckley N.V	$969M	+7.2%	+4.1%	+187.9%	—	+100.5%	-79.7%	-47.6%
CMPSCOMPASS Pathways plc	$952M	+73.3%	+51.3%	+163.6%	—	+17.1%	-72.3%	-65.8%
MNMDMind Medicine (MindMed) Inc.	$2.0B	—	+51.7%	+220.3%	—	+510.3%	-55.1%	+512.1%
NRXPNRx Pharmaceuticals, Inc.	$85M	+36.9%	+17.6%	+50.2%	—	-50.3%	-99.0%	-96.8%
CYBNCybin Inc.	$304M	—	-26.4%	-8.1%	—	-49.8%	-90.2%	-99.7%
CRONCronos Group Inc.	$969M	+0.4%	-5.9%	+27.0%	—	+27.6%	-65.2%	+1439.4%
CGCCanopy Growth Corporation	$119M	+6.7%	-6.7%	-17.2%	—	-91.6%	-99.5%	-94.4%
TLRYTilray Brands, Inc.	$648M	-17.6%	-42.8%	+1157.1%	—	+100.0%	-63.0%	-75.2%
ACBAurora Cannabis Inc.	$193M	-0.6%	-21.4%	-28.2%	—	-47.5%	-95.9%	-92.1%
INVAInnoviva, Inc.	$1.7B	-3.1%	+15.2%	+23.2%	—	+96.0%	+94.5%	+95.6%

Compare:LEXX vs ATAI LEXX vs CMPS LEXX vs MNMD LEXX vs ATAI vs CMPS

About LEXX Dividend Returns

Lexaria Bioscience Corp. (LEXX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of LEXX over the past year?

Lexaria Bioscience Corp. (LEXX) delivered a return of -42.47% over the past year. Since LEXX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in LEXX be worth today?

A $10,000 investment in Lexaria Bioscience Corp. one year ago would be worth $5,753 today, representing a loss of $4,247.

Q3Does LEXX pay dividends?

Lexaria Bioscience Corp. (LEXX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For LEXX, the total return equals the price-only return.

Q4Did LEXX beat the S&P 500?

No, Lexaria Bioscience Corp. (LEXX) underperformed the S&P 500 by 73.01 percentage points over the past year. LEXX delivered a total return of -42.47%, compared to the S&P 500's 30.54%. This means a passive S&P 500 index fund outperformed LEXX by 73.01pp during this period.

Q5What is LEXX's worst drawdown?

Lexaria Bioscience Corp. (LEXX) experienced a maximum drawdown of -65.29% over the past year, declining from its peak on 2025-09-25 to its trough on 2025-12-26. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is LEXX's long-term total return over 10, 20, or 30 years?

Here are Lexaria Bioscience Corp. (LEXX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -86.4% (-18.1% CAGR) — $10,000 would have grown to $1,361. Over 20 years: -86.4% total return (-9.5% CAGR) — $10,000 → $1,361. Over 30 years: -86.4% total return (-6.4% CAGR) — $10,000 → $1,361. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was LEXX's best and worst year?

Lexaria Bioscience Corp.'s best calendar year was 2024 with a total return of 62.8%. Its worst year was 2025 with a total return of -73.2%. This range shows the volatility investors should expect — the difference between the best and worst year is 136.0 percentage points.